Abbott Laboratories Inc. Nets $117M Contract for Cardiovascular Procedural Packages
Abbott Laboratories Inc., Santa Clara, California, has been awarded a maximum $117,140,796 fixed-price, indefinite-delivery/indefinite-quantity contract for cardiovascular procedural packages and supplies. This was a sole-source acquisition using justification 10 U.S. Code 2304 (c)(2), as stated in Federal Acquisition Regulation 6.302-2. This is a one-year contract with four one-year option periods. The ordering period end date is April 16, 2025. Using customers are Army, Navy, Air Force, Marine Corps and federal civilian agencies. Type of appropriation is fiscal 2024 through 2025 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DE-24-D-0015).
